Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Formulations
19 Cr
Low Risk
29.4
43.8
2.5
1.5
95.14
15.79
Sales CAGR
1Y
4.33%
3Y
0.44%
5Y
4.28%
10Y
2.52%
Profit CAGR
1Y
11.63%
3Y
-0.33%
5Y
9.36%
10Y
5.62%
ROE
TTM
5.08%
3Y
4.58%
5Y
4.74%
10Y
4.34%
ROCE
TTM
7.80%
3Y
6.76%
5Y
6.42%
10Y
5.99%
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
2
Neutral
4
Bullish
8
Bearish
21
Neutral
16
Bullish
9
Bearish
19
Neutral
12
Bullish
1
Performance
MARKET LEADER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Market Cap
₹ 19 Cr
P/E
29.37